David Einhorn: portfolio of Greenlight Capital

David Einhorn leads Greenlight Capital, which follows a value approach; short sales do not appear in the 13F report.

Source: 13F filing with the US Securities and Exchange Commission dated May 15, 2023. It shows positions at quarter end and is filed up to 45 days later – today the positions may be several months old. It covers only securities traded on US exchanges, without short positions; securities traded only abroad and cash are not included.

You are looking at Q1 2023. Go to the latest filing (Q3 2026)

1.8B USDQ1 2023
Total value of stock positions
1.8B USD
Positions
39
Share of the ten largest
77.6%

The ten largest positions Q1 2023

  1. Green Brick Partners Inc 31.6%▼ −1.8%
  2. Consol Energy Inc New 8.6%▲ +49.9%
  3. Brighthouse Finl Inc 7.5%▼ −2.3%
  4. Kyndryl HLDGS Inc 6.8%▼ −5.6%
  5. Teck Resources Ltd 4.9%▲ +11.4%
  6. Tenet Healthcare Corp 4.6%▲ +116.6%
  7. The Odp Corp 4.0%▼ −1.2%
  8. Global Payments 3.4%▲ +26.9%
  9. Capri Holdings Limited 3.2%▲ +31.6%
  10. Black Knight Inc 2.9%new
Total value of stock positions per quarter, Q2 2013 to Q3 2026 (peak 8.0B USD).
Choose a quarter (54 filings)

All positions Q1 2023

Positions Q1 2023 per 13F filing, 11 of 11
Symbol Weight Shares Reported value Change Held since
Teck Resources Ltd 4.9% 2,491,218 90.9M USD +11.4% increased Q2 2020 12 quarters
SPDR Gold TR 2.3% 227,899 41.8M USD +8.8% increased Q2 2020 12 quarters
Consol Energy Inc New 8.6% 2,716,741 158.3M USD +49.9% increased Q4 2020 10 quarters
Danimer Scientific Inc 0.5% 2,550,000 8.8M USD +13.3% increased Q4 2020 10 quarters
Capri Holdings Limited 3.2% 1,244,040 58.5M USD +31.6% increased Q1 2021 9 quarters
Livanova PLC 2.5% 1,034,896 45.1M USD +23.4% increased Q2 2021 8 quarters
GPN Global Payments 3.4% 600,430 63.2M USD +26.9% increased Q4 2021 6 quarters
Concentrix Corp 1.4% 207,961 25.3M USD +116.6% increased Q2 2022 4 quarters
Tenet Healthcare Corp 4.6% 1,426,970 84.8M USD +116.6% increased Q4 2022 2 quarters
Gulfport Energy Corp 1.2% 283,000 22.6M USD +125.5% increased Q4 2022 2 quarters
Coya Therapeutics Inc < 0.1% 392,647 1.6M USD +0.1% increased Q4 2022 2 quarters

“Held since”: the first quarter from which the position appears in the 13F filing at every quarter end. It first appears at the end of that quarter – the filing gives neither date nor price, and trading between two quarter ends is not visible. “Or earlier”: the position was already in the first available filing (or the first one after a gap in filings). After a change of the security identifier (e.g. a renaming) the start may appear later.

Breakdown by sector

  • Financials 3.4%
  • not in our coverage 96.6%

Sectors only for stocks we cover; the rest is grouped under “not in our coverage”.

How to read this page

  • Weight: a position’s share of the total value of all reported stock positions in this quarter – options and bonds are not counted.
  • Change: number of shares compared with the previous quarter. After a stock split we convert the previous quarter’s share count so that a split does not look like an increase; if a possible split cannot be confirmed, “–” is shown.
  • Reported value: value of the position at quarter end as reported by the investor. The portfolio may have changed since then.

All superinvestor portfolios Screener: stocks held by superinvestors

↑ ↓ select · Enter open · Esc close